Show simple item record

dc.contributor.authorTheodoros, Theo
dc.contributor.authorTaylor, Mark
dc.contributor.authorHuang, Hannah Chu-Han
dc.contributor.authorWang, Nancy
dc.contributor.authorMotamarri, Balaji
dc.date.accessioned2020-01-22T05:46:53Z
dc.date.available2020-01-22T05:46:53Z
dc.date.issued2018
dc.identifier.issn1039-8562
dc.identifier.doi10.1177/1039856218758559
dc.identifier.urihttp://hdl.handle.net/10072/390735
dc.description.abstractObjectives: The aim of this study is to provide an opinion paper reviewing the role of depot or long-acting injectable (LAI) antipsychotic medications, with comments on individual newer LAIs such aripiprazole maintena and paliperidone palmitate. In particular, we share our recent experience of using paliperidone three-monthly LAI. We also reflect on the associated benefits and potential harms of LAIs, and when they may be used. Conclusions: LAI antipsychotics are an important and arguably under-utilised therapeutic option, particularly where medication adherence is a priority, and where an informed patient opts for this formulation. Paliperidone is the first three-monthly LAI antipsychotic, and as such represents a significant advance in the range of treatment choices.
dc.description.peerreviewedYes
dc.languageEnglish
dc.language.isoeng
dc.publisherSage Publications
dc.relation.ispartofpagefrom303
dc.relation.ispartofpageto306
dc.relation.ispartofissue3
dc.relation.ispartofjournalAustralasian Psychiatry
dc.relation.ispartofvolume26
dc.subject.fieldofresearchMedical and Health Sciences
dc.subject.fieldofresearchPsychology and Cognitive Sciences
dc.subject.fieldofresearchcode11
dc.subject.fieldofresearchcode17
dc.subject.keywordsScience & Technology
dc.subject.keywordsLife Sciences & Biomedicine
dc.subject.keywordsPsychiatry
dc.subject.keywordslong-acting injectables
dc.subject.keywordsdepot
dc.titleGoing the distance: reviewing antipsychotic depot or long-acting injectable treatments in Australasia
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationTheodoros, T; Taylor, M; Huang, HC-H; Wang, N; Motamarri, B, Going the distance: reviewing antipsychotic depot or long-acting injectable treatments in Australasia, Australasian Psychiatry, 2018, 26 (3), pp. 303-306
dc.date.updated2020-01-22T05:45:16Z
gro.hasfulltextNo Full Text
gro.griffith.authorMotamarri, Balaji


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record